---
figid: PMC4810382__jpm-06-00003-g002
figtitle: EGFR- and ALK-signaling pathways and their respective inhibitors
organisms:
- Diaporthe sclerotioides
- Aegilops tauschii
- Homo sapiens
- Rattus norvegicus
- Turdus migratorius
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC4810382
filename: jpm-06-00003-g002.jpg
figlink: /pmc/articles/PMC4810382/figure/jpm-06-00003-f002/
number: F2
caption: Overview of the EGFR- and ALK-signaling pathways and their respective inhibitors.
  Ligand binding to EGFR leads to dimerization of the receptor, resulting in phosphorylation
  of the tyrosine kinase domain and activation of the PIK3/AKT/mTOR or the RAS/RAF/MEK/ERK
  signaling pathway. This signal transduction cascade could also be activated via
  EML4-Alk which, in turn, may initiate the JAK/STAT pathway. The affected pathways
  control cell growth and play a role in cell differentiation.
papertitle: 'Molecular Pathology and Personalized Medicine: The Dawn of a New Era
  in Companion Diagnostics—Practical Considerations about Companion Diagnostics for
  Non-Small-Cell-Lung-Cancer.'
reftext: Till Plönes, et al. J Pers Med. 2016 Mar;6(1):3.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9596038
figid_alias: PMC4810382__F2
figtype: Figure
redirect_from: /figures/PMC4810382__F2
ndex: b1b6d7bd-deb8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4810382__jpm-06-00003-g002.html
  '@type': Dataset
  description: Overview of the EGFR- and ALK-signaling pathways and their respective
    inhibitors. Ligand binding to EGFR leads to dimerization of the receptor, resulting
    in phosphorylation of the tyrosine kinase domain and activation of the PIK3/AKT/mTOR
    or the RAS/RAF/MEK/ERK signaling pathway. This signal transduction cascade could
    also be activated via EML4-Alk which, in turn, may initiate the JAK/STAT pathway.
    The affected pathways control cell growth and play a role in cell differentiation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CG
  - KRAS
  - HRAS
  - NRAS
  - EML4
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - ALK
  - MTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - EPHB2
  - MAPK1
  - MAPK3
  - EGFR
  - Eml4
  - Akt1
  - Alk
  - Mtor
  - Ephb1
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - Raf
  - Tor
  - Dsor1
  - Mtk
  - hop
  - bsk
  - Stat92E
  - Erk7
  - rl
  - LY294002
  - PD184352
  - Tipifarnib
  - Canertinib
  - Neratinib
  - Selumetinib
  - Trametinib
  - Dabrafenib
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
